---
title: "Ascendis Pharma Allocates $25 Million for Share Repurchases, Net Settlement of RSUs"
date: "2025-02-13 17:09:02"
summary: "Ascendis Pharma said late Wednesday its board has allocated $25 million to fund a share buyback program and the net settlement of certain restricted stock units, or RSUs. The buyback program authorizes the repurchase from time to time of up to about $18.3 million of American depositary shares. The company..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Ascendis Pharma said late Wednesday its board has allocated $25 million to fund a share buyback program and the net settlement of certain restricted stock units, or RSUs.

The buyback program authorizes the repurchase from time to time of up to about $18.3 million of American depositary shares.

The company also plans to apply a net settlement of tax-withholding obligations related to certain RSUs for about $9 million in cash.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250213:A3316238:0/)
